Overview
Registration
Faculty
Agenda
View Archive

Accreditation/
Credit Designation

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from MorphoSys US Inc.

Illustrated Case Discussions: How Will You Leverage Recent Evidence in Relapsed/Refractory DLBCL Settings?

Illustrated Case Discussions: How Will You Leverage Recent Evidence in Relapsed/Refractory DLBCL Settings?


Tuesday, September 1st, 2020
7:00-8:30 PM EST

Illustrated Case Discussions: How Will You Leverage Recent Evidence in Relapsed/Refractory DLBCL Settings?

Overview

Diffuse large B-cell lymphoma (DLBCL) is among the most common forms of non-Hodgkin lymphoma with an estimated 28,000 cases diagnosed in the United States each year. Historically, a combination of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) has been the standard of care for patients with DLBCL; and while R-CHOP is associated with an approximate 60% cure rate, 40% of patients are either refractory to R-CHOP or will relapse following treatment response. Accordingly, there is a growing armamentarium of treatments available for the management of relapsed/refractory DLBCL including anti-CD19 antibodies, CAR-T therapies, antibody-drug conjugates, and nuclear transport inhibitors. With expanding treatment options comes the challenge of determining best practices for patient care. In addition, numerous agents are currently in late-stage clinical trials, including PI3K and BTK inhibitors, immunomodulatory drugs, and checkpoint inhibitors which may influence treatment approaches in the future

This CME-certified live webcast will provide clinicians with expert perspectives on the management of patients with transplant-ineligible DLBCL, with a focus on therapies for treatment in the relapsed/refractory setting. The renowned panel of experts will share evidence and best practices in a case-based format for integrating newly approved agents into the management of relapsed/refractory DLBCL, as well as review emerging agents in the ever-expanding treatment landscape.

Target Audience

These activities are intended for medical oncologists, hematologists, and other oncology healthcare professionals interested in the latest advances in the treatment of patients with diffuse large B-cell lymphoma (DLBCL). Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of patients with DLBCL are also invited to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:
  • Assess current standards of care in the management of patients with DLBCL and unmet medical needs in therapy
  • Integrate evidence from landmark clinical trials among patients with relapsed/refractory in the context of clinical scenarios
  • Identify approaches to diagnose and manage treatment-related toxicities among patients with DLBCL
  • Discuss emerging therapies and ongoing clinical trials for patients with relapsed/refractory DLBCL
This activity is supported by an educational grant from MorphoSys US Inc.

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Chair

Christopher R. Flowers, M.D., M.S. FASCO
Christopher R. Flowers, M.D., M.S. FASCO
Professor, Department Chairman (Lymphoma/Myeloma)
University of Texas MD Anderson Cancer Center
Houston, Texas

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
27282930
Filter By